Filing Details

Accession Number:
0001181431-12-029232
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-10 20:17:29
Reporting Period:
2012-05-10
Filing Date:
2012-05-10
Accepted Time:
2012-05-10 19:17:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1275857 A James Mcnulty C/O Biodelivery Sciences Intl, Inc.
801 Corporate Center Drive, Suite 210
Raleigh NC 27607
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-08 6,093 $2.01 49,252 No 4 M Direct
Common Stock Acquisiton 2012-05-08 15,603 $2.05 64,855 No 4 M Direct
Common Stock Disposition 2012-05-08 21,696 $4.00 43,159 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options Disposition 2012-05-08 6,093 $0.00 6,093 $2.01
Common Stock Options Disposition 2012-05-08 15,603 $0.00 15,603 $2.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,092 2009-07-24 2018-07-24 No 4 M Direct
0 2007-07-27 2016-07-27 No 4 M Direct
Footnotes
  1. The sale of the shares of common stock was undertaken pursuant to a pre-arranged 10b5-1 plan previously implemented by the reporting person.